Abstract 044: Urinary Metals and Incident Heart Failure: A Multi-Cohort Study and Meta-Analysis

I Irene Martinez-Morata A Arce Domingo (Columbia University, New York, New York, United States) K Kathrin Schilling (Columbia University, New York, New York, United States) R Ronald Glabonjat (Columbia University, New York, New York, United States) K Katlyn McGraw (Columbia University, New York, New York, United States) J Joel Kaufman (UNIVERSITY WASHINGTON, Seattle, Washington, United States) W Wendy Post (JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland, United States) D Daichi Shimbo A Amanda Fretts (University of Washington School of Public Health, Seattle, Washington, United States) J Jason Umans (MedStar Health Research Institute, Bethesda, Maryland, United States) S Shelley Cole (Texas Biomedical Research Institute, San Antonio, Texas, United States) M Maria Tellez-Plaza (Department of Chronic Disease Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain (M.T.-P.).) L Linda Valeri (Columbia University, New York, New York, United States) R R. Graham Barr (Columbia University, New York, NY, USA.) S Steven Shea (Columbia University, New York, New York, United States) R Richard Devereux (Weill Cornell Medicine, New York, New York, United States) A Ana Navas-Acien (Columbia University, New York, New York, United States)

Abstract

Background: Environmental metals are recognized risk factors for cardiovascular disease, yet the role of urinary metals and metal mixtures on incident heart failure (HF) remains understudied. Objectives: To evaluate the prospective association of urinary metals on incident HF risk across three geographically and ethnically/racially diverse cohorts: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Strong Heart Study (SHS) in the United States, and the Hortega cohort in Spain. Methods: A total of 6,644, 2,917, and 1,334 adults 35-80 years old were included across MESA (39% non-Hispanic white, 27% non-Hispanic Black, 22% Hispanic/Latino, 12% Chinese-descent), SHS (100% American Indian), and Hortega (100% white), and followed up to 19 years. Urinary levels of inorganic arsenic, cadmium, molybdenum, selenium, and zinc were measured in all cohorts at baseline. The multi-adjusted (sociodemographic + clinical covariates) hazard ratios (HR) of HF per one interquartile range (IQR) difference in urinary metals were estimated for each metal using Cox proportional hazard models and a fixed-effects meta-analysis was run for each metal across cohorts. Flexible dose-response assessment was conducted using quadratic splines. We further estimated the HRs and 10-year-survival probability difference per IQR change in the mixture of five metals using Cox proportional hazard models with an Elastic Net penalty. Results: A total of 425 (MESA), 477 (SHS), and 103 (Hortega) participants developed HF over the study follow-up. Significant associations were identified for arsenic (Pooled HR (95%CI): 1.06 (1.00, 1.12), cadmium (HR: 1.15 (1.07, 1.24)), molybdenum (HR:1.14 (1.03, 1.26)), and zinc (HR: 1.23 (1.02, 1.49)) in the meta-analyses (Figure 1). A largely linear dose-response was identified for arsenic and cadmium (Figure 2). In fully adjusted models, the HRs (95% CI) and 10-year survival probability differences (95% CI) of incident HF per one IQR increase in the metal mixture were, respectively, 1.38 (1.00, 1.86) and -0.40 (-0.78, 0.00) in MESA, 1.55 (1.28. 1.97) and -1.24 (-2.20, -0.59) in SHS, and 1.08 (0.85, 1.63), and -0.03 (-0.21, 0.06) in Hortega. Conclusion: This multi-cohort study identified consistent associations between higher urinary metals and increased risk of heart failure across diverse populations, supporting the role of prevention strategies to reduce contaminant metal exposure to lower HF risk.

Article Details

Journal Circulation
Volume / Issue Vol. 151, Issue Suppl_1
Published March 11, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (17)

I

Irene Martinez-Morata

A

Arce Domingo

Columbia University, New York, New York, United States

K

Kathrin Schilling

Columbia University, New York, New York, United States

R

Ronald Glabonjat

Columbia University, New York, New York, United States

K

Katlyn McGraw

Columbia University, New York, New York, United States

J

Joel Kaufman

UNIVERSITY WASHINGTON, Seattle, Washington, United States

W

Wendy Post

JOHNS HOPKINS UNIVERSITY, Baltimore, Maryland, United States

D

Daichi Shimbo

A

Amanda Fretts

University of Washington School of Public Health, Seattle, Washington, United States

J

Jason Umans

MedStar Health Research Institute, Bethesda, Maryland, United States

S

Shelley Cole

Texas Biomedical Research Institute, San Antonio, Texas, United States

M

Maria Tellez-Plaza

Department of Chronic Disease Epidemiology, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain (M.T.-P.).

L

Linda Valeri

Columbia University, New York, New York, United States

R

R. Graham Barr

Columbia University, New York, NY, USA.

S

Steven Shea

Columbia University, New York, New York, United States

R

Richard Devereux

Weill Cornell Medicine, New York, New York, United States

A

Ana Navas-Acien

Columbia University, New York, New York, United States